Ospedale Ruber Internacional
Ospedale Ruber Internacional
Spagna, Madrid
Enrique Grande
21 anni di esperienza
Clinica certificata da :
| Turchia | Austria | Spagna | |
| Terapia con Bacillo di Calmette-Guérin (BCG) | da $1,200 | da $2,400 | da $3,200 |
| Terapia con Actinio-225 | da $22,955 | da $55,000 | da $45,000 |
| Rimozione della vescica con ricostruzione | da $15,000 | da $32,000 | da $25,000 |
| Rimozione della vescica | da $8,000 | da $22,000 | da $25,000 |
| Radioterapia per il cancro colorettale | da $7,000 | da $12,000 | da $10,000 |
Dr. Enrique Grande, MD, PhD, MSc, is a medical oncologist with more than 20 years of experience. He is an international expert in genitourinary and neuroendocrine tumors. He directs the Medical Oncology Department and the One Oncology Madrid Cancer Program at QuirónSalud, Spain’s largest private healthcare network. He leads an integrated, multidisciplinary model with access to targeted therapies and clinical trials.
He is a pioneer in precision oncology. He uses molecular profiling and biomarker-based care. He has authored more than 300 peer-reviewed papers. He serves as a principal investigator and sits on steering committees for many international trials. These studies help set standards of care in urothelial bladder and neuroendocrine tumors. He contributes to guidelines and programs at ESMO, ASCO, ENETS, and EAU.
Il medico dirige il Dipartimento di Urologia e trapianto di rene presso il Centro Medico Teknon a Barcellona, Spagna, con oltre 30 anni di esperienza. Specializzandosi in uro-oncologia e trapiantologia, il medico ha supervisionato oltre 500 operazioni di successo, concentrandosi su patologie del sistema urogenitale utilizzando metodi minimamente invasivi, inclusi interventi laparoscopici e assistiti da robot.<\/p>
Il medico è particolarmente noto per la sua esperienza nel trattamento del cancro alla prostata e utilizza il sistema robotico Da Vinci per procedure chirurgiche innovative. Inoltre, il medico tratta patologie congenite nei bambini come il criptorchidismo ed è membro della Confederazione Urologica Americana, dell'Associazione Urologica Spagnola e della Società Europea di Urologia.<\/p>
Il medico possiede una laurea in Medicina presso l'Università Complutense di Madrid e un dottorato presso l'Università di Barcellona. Specializzandosi in Ematologia e Oncologia Pediatrica presso l'Università del Maryland, il medico è esperto nel trattamento di tumori ossei e cerebrali, nonché di leucemia e malattie ematologiche.<\/p>
Con oltre due decenni di esperienza, il medico attualmente dirige l'Unità di Ematologia e Oncologia Pediatrica presso l'Ospedale HM Montepríncipe, concentrandosi sulla cura di bambini e adolescenti. In precedenza, il medico ha ricoperto la stessa posizione presso l'Ospedale Universitario Clínica San Rafael ed è autore di numerose pubblicazioni scientifiche.<\/p>
Dr. Begona Mellado Gonzalez is a senior oncologist specializing in urological cancers at Hospital HM Nou Delfos. She has published over 140 scientific articles in international journals. Dr. Mellado Gonzalez completed a post-doctoral stay at Memorial Sloan-Kettering Cancer Center in New York. She serves as a leading researcher for prostate cancer at the IDIBAPS institute.
Standard care for bladder cancer in Spain includes transurethral resection for non-invasive cases. Leading centers utilize neoadjuvant chemotherapy and radical cystectomy for muscle-invasive disease. JCI-accredited facilities in Barcelona and Madrid prioritize robotic-assisted surgery and targeted immunotherapies like Pembrolizumab to improve patient survival rates.
Bookimed Expert Insight: Spanish private centers offer significantly faster access to high-cost immunotherapies compared to public health timelines. While public waits for diagnosis can reach 3 to 6 months, clinics like Centro Médico Teknon provide immediate access to Keytruda. Our data shows these facilities often bundle diagnostic programs for approximately $1,400, allowing for rapid staging before starting intensive treatment.
Patient Consensus: Patients note that seeking private care helps avoid long public waiting lists for routine cystoscopies. Many emphasize the importance of aggressive recurrence tracking every 3 months after completing initial BCG therapy.
Immunotherapy is widely available in Spain for various malignancies including bladder cancer. Specialized oncology centers in Barcelona and Madrid offer advanced checkpoint inhibitors like Keytruda. These facilities maintain Joint Commission International accreditation and participate in leading international oncology clinical trials.
Bookimed Expert Insight: Patients should note that immunotherapy in Spain often requires a specific diagnostic baseline. Packages at Centro Medico Teknon include complete blood counts with cancer markers and proteinograms. This ensures the 200 mg Keytruda dose is precisely calibrated to the patient's current health status.
Patient Consensus: Patients value the efficiency of Spanish private clinics where multidisciplinary teams coordinate diagnostics quickly. Many emphasize that having a dedicated coordinator helps manage the logistics of multi-cycle treatment plans.
Spanish hospitals utilize Da Vinci robotic systems and AI-powered imaging for cancer screening and precision surgery. High-volume centers in Madrid and Barcelona integrate PET-CT and CT diagnostics with advanced treatments like immunotherapies and proton radiotherapy. Clinics often hold Joint Commission International and Newsweek certifications for oncology excellence.
Bookimed Expert Insight: Spanish oncology centers like Centro Médico Teknon and Hospital Quiron Barcelona show a strong trend toward combining robotic expertise with research collaboration. Dr. Antonio Alcaraz at Quiron Barcelona has performed over 500 robotic procedures. Choosing a clinic with such high-volume surgical data often correlates with better functional preservation for patients.
Patient Consensus: Patients emphasize the importance of requesting blue-light TURBT for better tumor detection compared to standard methods. Many note that private facilities in Madrid and Barcelona provide much faster access to robotic equipment than regional public hospitals.
Leading certified hospitals for bladder cancer in Spain include JCI-accredited facilities like Centro Médico Teknon and Hospital Ruber Internacional. These centers utilize robotic Da Vinci systems and immunotherapy protocols. Specialty oncology boards oversee complex cases. Spanish institutions maintain high safety standards through international certifications.
Bookimed Expert Insight: Spanish oncology centers offer distinct value by providing specialized diagnostic packages. For example, Centro Médico Teknon offers a diagnostic program for $1,400. This is significant because it includes direct evaluation by specialists like Dr. Jose Emilio Batista Miranda. Accessing these structured programs ensures all necessary pathology reviews occur before starting expensive immunotherapy or surgery.
Patient Consensus: Patients note that seeking second opinions at major university hospitals helps avoid overtreatment. They emphasize confirming if robotic surgery or intravesical therapy is available before traveling.
Recognised expert uro-oncologists for bladder cancer include practitioners at top Spanish institutions such as Hospital Quiron Barcelona and Hospital Ruber Internacional. These specialists utilize robotic-assisted surgery and advanced immunotherapy. Leading experts hold certifications from the European Association of Urology and the American Urological Association.
Bookimed Expert Insight: While many patients focus on large hospital groups, the specific experience of individual surgeons like Dr. Antonio Alcaraz, who has performed over 500 complex operations, is a stronger indicator of success. Data shows that highly specialized centers like Clínica Universidad de Navarra, which was the first in Spain to receive JCI certification, often provide faster access to robotic-assisted procedures than larger public networks.
Patient Consensus: Patients emphasize the value of private consultations with high-volume surgeons in Barcelona or Madrid to bypass long public waiting lists. Reviewing a surgeon's specific history with neobladder reconstructions is a common priority for those seeking to maintain quality of life after surgery.
Spanish hospitals accommodate international patients through dedicated departments that provide multilingual support and logistics coordination. Facilities like Centro Medico Teknon and Clinica Universidad de Navarra offer 24/7 translation services. They also assist with medical visa applications and airport transfers to ensure seamless treatment.
Bookimed Expert Insight: Our data shows Spanish private groups like Quironsalud and HM Hospitales serve over 100,000 patients annually. These benchmarks reflect a high capacity for international volume. Patients should look for JCI-accredited centers in Barcelona or Madrid. These clinics frequently bundle diagnostics with specialist consultations, often costing around $1,400.
Patient Consensus: Patients find that private clinics eliminate the long wait times and language barriers common in public systems. Many note it is helpful to secure travel insurance and request English quotes before arrival.
Discuss the tumor stage, grade, and local recurrence risk to determine if the cancer is non-muscle invasive or muscle-invasive. Ask about advanced surgical options like Da Vinci robotic-assisted cystectomy or bladder-preserving therapies. Clarify the availability of immunotherapy drugs like Keytruda and participation in clinical trials.
Bookimed Expert Insight: Spain offers a significant experience gap in robotic surgery that patients should leverage. Leading surgeons like Dr. Antonio Alcaraz have performed over 500 successful operations. Choosing centers with 100,000+ annual patient volumes often ensures faster access to robot-assisted platforms for complex reconstructions.
Patient Consensus: Patients emphasize asking about neobladder reconstruction early to avoid permanent external bags. Many note that private clinics in Barcelona or Madrid significantly reduce wait times for radical procedures.
Spain offers bladder cancer treatments including robotic-assisted cystectomy, immunotherapies like Keytruda, and targeted therapies. Clinics in Madrid and Barcelona follow guidelines from the ESMO (European Society for Medical Oncology). They use the Da Vinci robotic system for precise organ-preserving surgeries.
Bookimed Expert Insight: Spain's oncology landscape is unique because specialists often hold dual expertise. Dr. Begona Mellado Gonzalez and Dr. Enrique Grande work in clinical research and active surgery. Many leading Spanish doctors have completed fellowships at institutions like Memorial Sloan-Kettering. This lets them integrate early-phase clinical trials into private patient care plans.
Patient Consensus: Patients value the multidisciplinary tumour boards in Spain. They note that international coordinators effectively manage logistical details like sharing results and follow-up schedules.
Spanish oncologists use a standard framework to categorise bladder cancer based on tumour depth and risk. Specialists perform a transurethral resection of bladder tumour (TURBT). Doctors use this surgery to remove tissue and confirm the stage. They also check if cancer has reached the muscle layer.
Bookimed Expert Insight: Spanish oncology centres often focus on bladder-sparing strategies to help patients avoid radical surgery. Dr Antonio Alcaraz at Hospital Quiron Barcelona uses the Da Vinci robotic system for high-precision operations. This allows surgeons to preserve function while removing tumours. Many Australian patients find this to be a major benefit. Some centres are part of global networks like GenesisCare, providing familiar care standards.
Patient Consensus: Patients note that doctors in Spain prioritise accurate staging and grading before suggesting a final plan. They appreciate how specialists tailor treatments to the individual. These plans focus on whether a tumour is non-muscle-invasive or muscle-invasive.
Leading Spanish hospitals for bladder cancer include Centro Médico Teknon, Hospital Ruber Internacional and Hospital Quiron Barcelona. These JCI-accredited facilities offer robotic cystectomy, molecular diagnostics and immunotherapy. Patients access multidisciplinary care through dedicated tumour boards and specialist uro-oncologists for precise treatment plans.
Bookimed Expert Insight: Spanish oncology centres often function as academic hubs. Experts like Dr Begona Mellado Gonzalez participate in phase I–III clinical trials. This gives patients access to emerging therapies not yet widely available. Clinics like Quironsalud Torrevieja also provide support in 15 languages. This makes them highly accessible for international patients seeking specialised care.
Patient Consensus: Patients value tertiary centres in Spain that combine urology and medical oncology services. Experience suggests confirmed language assistance and fast-tracked diagnostics significantly reduce travel stress for Australians.
Bladder cancer treatment in Spain typically requires 2 to 8 weeks. Diagnostic programs take about 3 to 5 days. Major surgeries like radical cystectomy need 4 to 8 weeks for hospital recovery. Robotic procedures often allow for a faster return home within 2 weeks.
Bookimed Expert Insight: Spanish oncology centres like Centro Médico Teknon and Hospital Quiron Barcelona offer virtual consultations for Australians. This allows patients to stay at home while experts review pathology and scans. By confirming the plan remotely, patients can fly to Spain 1 day before surgery. This avoids 1–2 weeks of hotel costs while waiting for a diagnosis.
Patient Consensus: Patients note that stay length depends entirely on the specific procedure. When travelling from Australia, patients suggest adding extra days for safe return travel. Issues with catheters or pain control may delay discharge.
Language barriers do not interfere with bladder cancer treatment in Spain's private sector. Major hospitals provide dedicated international desks and language assistance. While public hospitals use Spanish, leading private centres maintain English-speaking medical teams for oncology cases. These teams assist with complex cases and surgical procedures.
Bookimed Expert Insight: Spanish oncology centres often bridge language gaps through international training. Dr Begona Mellado Gonzalez and Dr Lopez Ibor both completed specialist training in the United States. Choosing doctors with American or British fellowships typically ensures fluent communication during consultations and surgical planning.
Patient Consensus: Patients note that specialists often speak English, but administrative staff and nurses may not. It is vital to confirm interpreting support for ward communication and pharmacy visits in Spain.
International patients choose Spain for bladder cancer treatment to access robotic-assisted surgeries and immunotherapy without long wait times. Major centres maintain Joint Commission International (JCI) accreditation. These hospitals provide precise molecular profiling and specialist evaluations often unavailable or delayed elsewhere.
Bookimed Expert Insight: Spanish oncology networks like GenesisCare maintain clinics in Australia. This simplifies long-term surveillance after returning home. This connection is vital for bladder cancer. Patients require ongoing follow-up scans and cystoscopies. Choosing a Spanish network with Australian links helps medical records transfer smoothly between specialist teams.
Patient Consensus: Patients value how Spanish private clinics treat them as priority customers. They appreciate clear communication and English-speaking assistance. Many note that Spain offers better value for self-funded care compared to other private systems abroad.